Corporate Data

TOP > Corporate Data > Company History

Company History

1949 Established Kaneka Corporation with ¥200 million capital.
Developed polyvinyl chloride (PVC), Kanevinyl.
1950 Started first mass production of PVC, Kanevinyl, in Japan.
Started first production of PVC wire covering.
1952 Developed and marketed solution-type PVC, Kanevilack.
1953 Started large scale production of margarine and shortening.
Started production of flexible PVC compounds, Kanevinyl Compound.
1957 Developed and marketed Kanekalon.
1958 Awarded Deming Application Prize.
1960 Takasago Plant Kanevinyl facilities was completed and production began.
1961 Developed and marketed Belco.
1964 Developed and marketed Kane Ace B.
1965 Developed and marketed expandable polystyrene, Kanepearl.
Started sales of Kanekalon wig, Fontaine.
1966 Started first production of rigid PVC compounds, Kanevinyl Compound.
Developed and marketed heat resistant ABS resin, Kaneka MUH (Transferred in 2001).
1967 Developed a PVC paste, which began production and sales as Kanevinyl Paste.
1968 Established Europe office and New York office.
Developed and marketed chlorinated PVC.
Completed vinyl chloride monomer plant using oxychlorination process.
1970 Developed and marketed extruded polystyrene foam board, Kanelite Foam.
Established Kaneka Belgium N.V.
1971 Completed Kanepearl plant.
Established Kaneka America Corporation.
1972 Developed and marketed self-extinguishing ABS resin, Enplex.
1973 Received prize from the Society of Polymer Science of Japan for Kane Ace B resin manufacturing technology.
Developed and marketed polyethylene foam using bead method, Eperan.
Developed and marketed bonded magnet, Kaneka Flux.
Completed plant for Kane Ace B at Kaneka Belgium N.V.
1974 Developed Glutathione, pharmaceutical intermediate for hepatic medicines, using fermentation, and started production.
1977 Developed and marketed Ubidecarenone, pharmaceutical bulk for cardiac medicines.
1978 Developed and marketed weather-resistant MMA resin-based film, Sunduren.
1979 Established Kaneka Singapore Co. (Pte.) Ltd.
Developed and marketed Silyl terminated polyethers, Kaneka MS polymer.
1980 Marketed pharmaceutical intermediates, HPG.
1981 Received prize from the Society of Polymer Science of Japan for Kaneka MS Polymer.
1982 Marketed PVC sash window, Excel Window.
Received award from the Chemical Society of Japan for the technical development of D-para-hydroxyphenylglycine manufacturing technology.
Established Kaneka Texas Corporation (now Kaneka North America LLC).
1983 Received a "Nikkei Superior Product and Service Award" for Kanekalon's artificial fur from the Nikkei Marketing Journal.
Developed and marketed AMMPA Kaneka, intermediate for anti-hypertensive medicine.
Developed and marketed acrylic silicon polymer, Kaneka Gemlac.
1984 Received award from the Society of Fiber Science and Technology, Japan for flame retardant fiber technology.
Developed and marketed amorphous photovoltaic modules.
Developed and marketed polyimide film, Apical.
Completed plant for Kane Ace B at Kaneka Texas.
1985 Developed and marketed polypropylene foam using bead method, Eperan PP.
Completed plant for Eperan at Kaneka Belgium N.V.
1986 Commercialized blood purification system and commenced production and sale of the SULFLUX membrane-type plasma separator and the LIPOSORBER low-density lipoprotein(LDL) absorber.
Received prize from the Society of Fermentation Technology, Japan for ß-hydroxy fatty acid.
1987 Received prize from the Society of Fiber Science and Technology, Japan for Kanekalon coloring and spinning method.
1988 Received Inoue Harushige Award from the Research Development Corporation of Japan for amorphous photovoltaic modules research and commercialization.
1989 Established Allied-Apical Co (now Kaneka North America LLC).
Received award from the Society of Polymer Science of Japan for plasmapheresis system.
Developed modified PET resin, Kaneka Hyperite.
1990 Started production of Eperan and Eperan PP at Kaneka Texas.
Started production of Apical at Allied-Apical Co.
1991 Developed and marketed Selesorb, a selective adsorption column for systemic lupus erythematosus.
1992 Received award from the Japan Institute of Invention and Innovation for MS Polymer.
Established Kaneka Technical Service Co., Ltd. Shanghai.
1993 Established Nantong Sunrise Worsted Spinning Co., Ltd. as a joint venture with Kyusyu Kanekalon Co., Ltd. Kanematsu Corporation, and Toyobo Co., Ltd.
Received award from the Kinki Chemical Society, Japan, for Apical NPI.
Received award from the Society of Fiber Science and Technology, Japan, for Protex, a flame retardant fiber.
1994 Manufacturing approval obtained for Lixelle plasma purification device for use in the treatment of dialysis-related amyloidosis.
Established Kaneka Pharma Europe N.V.
1995 Marketed transparent film, Elmech.
Established Kaneka (Malaysia) Sdn. Bhd.
1996 Established Kaneka Delaware Corporation.
Established Kaneka Plastics Corporation.
Established Kaneka Eperan Sdn. Bhd.
1997 Established Kaneka Pharma America LLC.
Kaneka Malaysia began production of Eperan and MBS resin.
Established Kaneka High-Tech Materials (now Kaneka north America) to carry on the business operations of Allied-Apical.
Kashima plant production facilities completed for Epion liquid polyisobutylene resin.
Kaneka Belgium began production of MS polymer.
1998 Established Kaneka Consulting (Shanghai) Co., Ltd. (now Kaneka Trading (Shanghai) Co., Ltd.).
1999 Established Kaneka Paste Polymers Sdn. Bhd.
2000 Acquired ISO 14001 registration at four plants in Japan.
Attained ISO 9001 certification for all related company divisions (an industry first) involved in making Kanelite Foam.
Started domestic sales of photovoltaic solar power generation system.
Completed new Eperan factory in Michigan for Kaneka Texas Corporation.
Constructed life sciences research divisions.
Developed word's first non-fluorocarbon, non-halogen foaming agent Kanelite Foam, JIS category 3 insulation panel.
2002 Began to sell the functional food material Kaneka Coenzyme Q10.
Began to sell large-area see-through type photovoltaic modules.
Began to sell nation's first embolization coil.
2003 Established HiHua Fiber Co., Ltd in China.
Established Suzhou Eperan Plastic Ltd. (now Kaneka Eperan (Suzhou) Co., Ltd).
Developed an imide film capable of forming a three-dimensional optical waveguide with a laser.
2005 Developed an industry's first Acryl grafted-Vinyl Chloride copolymer, PRICTMER.
2006 Industrialized world's first Telechelic polyacrylate.
Developed a new injection molding resin by applying proprietary nanocomposite technology.
Developed toughness-enhancing master batches for epoxy resin.
2007 Established Kaneka Pharma Vietnam Co.,Ltd & KSS Vietnam Co., Ltd.
2008 Achieved Zero-emission status at all production facilities in Japan for the second straight year.
Developed a new resin with high mechanical strength and high light resistance, ILLUMIKA.
Developed world's most advanced high thermal conductive graphite sheet, Graphinity.
Began commercial production of the isobutylene thermoplastic elastomer SIBSTAR.
2009 Established Photovoltaic & Thin Film Device Research Laboratories.
Established Solar Cell Research Division in Kaneka Belgium.
Established KM Transderm Ltd.
2010 Developed new thermally conductive plastics with electric insulating properties.
Developed the industry’s first dual UV/moisture-curing adhesive in collaboration with Chemtech.
Established Kaneka India Pvt.Ltd.
Formed a capital alliance with Belgian biotechnology firm, Eurogentec S.A.
Rolled out Organic EL Lighting Panels Business.
Established GeneFrontier Corporation.
Established Kaneka Innovative Fibers Sdn.Bhd.
2011 Developed world's first completely bio-based polymer with soft and heat-resistant properties
Received prize from the Society of Polymer Science of Japan for Telechelic polyacrylate.
Established Kaneka Modifiers Deutschland GmbH.
Established Kaneka Taiwan Corporation.
Established Kaneka Korea Corporation.
Established Kaneka (Foshan) High Performance Materials Co.,Ltd.
Developed a new thermosetting imide resin for a carbon-fiber-reinforced composite material with high heat-resistance.
Received prize from the 21th International Photovoltaic Science and Engineering Conference.
2012 Established Kaneka Asia Co., Ltd., an Asia regional holding company based in Shanghai, China.
Established Kaneka Americas Holding, Inc., an Americas regional holding company based in Texas, USA.
Began to sell KANEKA KanCapA selected by global pharmaceutical companies.
Established Kaneka Apical Malaysia Sdn. Bhd.
2013 Established Kaneka South America Representative Ltd in Brazil.
Established PT.Kaneka Foods Indonesia.
Established Kaneka US Material Research Center Facility within Texas A&M.
Began to sell CellEffic BM in Europe.
2014 Commenced sale of organic EL lighting panels with the world’s longest service life and excellent color stability.
Lacriflow tear duct tubes went on sale in the United States.
Developed Ikazuchi Zero catheter and commenced sale of this product for use in percutaneous coronary arterioplasty.
2015 Signed the United Nations Global Compact, a concept advocated by former UN Secretary-General.
Kaneka Europe Holding company N.V. was established to accelerate business expansion in Europe, the Middle East and Africa(EMEA).
A PTA balloon catheter jointly developed with Terumo Corporation for use in peripheral blood vessel therapy went on sale in the United States.
Kaneka MS Malaysia Sdn.Bhd., a new Kaneka MS Polymer production plant, was established.
A research facility specializing in regenerative medicine and cell therapy was established in Kobe.
2016 Acquired a shareholding in Cemedine Co., Ltd., which became a consolidated subsidiary.
Opened Kaneka Africa Liaison office in Ghana to accelerate business development in Africa.
Established Kaneka US Innovation Center.
2017 Established Kaneka Hokkaido Co.,Ltd.
Page Top